Inorevia develops and markets new generation instruments for Research and Medicine. These robots use breakthrough technologies, developed by a team of researchers from the Institut Curie, to miniaturize biological reactions. This change in scale makes it possible to reduce costs and analysis times, and will make it possible to respond to the challenges of tomorrow's medicine and biology for which automation, parallelization and miniaturization are essential.
Original laboratory/Establishment: Institut Curie, UMR168 - MMBM team
President: Julien Autebert
